NFE2L2 and acute myeloid leukemia: The present findings demonstrated that Nrf2 was significantly increased in both protein and mRNA levels in mutated AML patients compared with non-mutated patients, and the expression of Nrf2 also increased with the increase of the prognostic risk of gene mutation, suggesting that Nrf2 may be a potential factor that increases the risk of AML gene mutation.